Referências
Principais artigos
Lam DS, Houang E, Fan DS, et al. Hong Kong Microbial Keratitis Study Group. Incidence and risk factors for microbial keratitis in Hong Kong: comparison with Europe and North America. Eye. 2002 Sep;16(5):608-18.Texto completo Resumo
Toshida H, Kogure N, Inoue N, et al. Trends in microbial keratitis in Japan. Eye Contact Lens. 2007 Mar;33(2):70-3. Resumo
Srinivasan M, Mascarenhas J, Rajaraman R, et al; Steroids for Corneal Ulcers Trial Group. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol. 2012 Feb;130(2):143-50.Texto completo Resumo
Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2015 Jan 9;(1):CD002898.Texto completo Resumo
Kaufman HE, Haw WH. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis. Curr Eye Res. 2012 Jul;37(7):654-60. Resumo
Guess S, Stone DU, Chodosh J, et al. Evidence-based treatment of herpes simplex virus keratitis: a systematic review. Ocul Surf. 2007 Jul;5(3):240-50. Resumo
Artigos de referência
1. Rhee DJ, Pyfer MF. The Wills eye manual. Baltimore: Lippincott, Williams & Wilkins, 1999.
2. Sharma S. Keratitis. Biosci Rep. 2001 Aug;21(4):419-44. Resumo
3. Erie JC, Nevitt MP, Hodge DO, et al. Incidence of ulcerative keratitis in a defined population from 1950 through 1988. Arch Ophthalmol. 1993 Dec;111(12):1665-71. Resumo
4. Lam DS, Houang E, Fan DS, et al. Hong Kong Microbial Keratitis Study Group. Incidence and risk factors for microbial keratitis in Hong Kong: comparison with Europe and North America. Eye. 2002 Sep;16(5):608-18.Texto completo Resumo
5. Basak SK, Basak S, Mohanta A, et al. Epidemiological and microbiological diagnosis of suppurative keratitis in gangetic West Bengal, Eastern India. Indian J Ophthalmol. 2005 Mar;53(1):17-22. Resumo
6. Kinota S, Wong KW, Biswas J, et al. Changing patterns of infectious keratitis: overview of clinical and histopathologic features of keratitis due to Acanthamoeba or atypical Mycobacteria, and of infectious crystalline keratopathy. Indian J Ophthalmol. 1993 Apr;41(1):3-14.Texto completo Resumo
7. Toshida H, Kogure N, Inoue N, et al. Trends in microbial keratitis in Japan. Eye Contact Lens. 2007 Mar;33(2):70-3. Resumo
8. Upadhyay MP, Karmacharya PC, Koirala S, et al. The Bhaktapur eye study: ocular trauma and antibiotic prophylaxis for the prevention of corneal ulceration in Nepal. Br J Ophthalmol. 2001 Apr;85(4):388-92. Resumo
9. Bharathi MJ, Ramakrishnan R, Vasu S, et al. Aetiological diagnosis of microbial keratitis in South India: a study of 1618 cases. Indian J Med Microbiol. 2002 Jan-Mar;20(1):19-24.Texto completo Resumo
10. McKibbin M, Isaacs JD, Morrell AJ. Incidence of corneal melting in association with systemic disease in the Yorkshire Region, 1995-7. Br J Ophthalmol. 1999 Aug;83(8):941-3.Texto completo Resumo
11. Kaiser PK, Friedman NJ. The Massachusetts eye and ear infirmary illustrated manual of ophthalmology. New York: Elsevier Science, 2004.
12. Agrawal V, Biswas J, Madhavan HN, et al. Current perspectives in infectious keratitis. Indian J Ophthalmol. 1994 Dec;42(4):171-92.Texto completo Resumo
13. Dana MR, Qian Y, Hamrah P. Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection. Cornea. 2000 Sep;19(5):625-43. Resumo
14. Mondino BJ. Inflammatory diseases of the peripheral cornea. Ophthalmology. 1988 Apr;95(4):463-72. Resumo
15. Thebpatiphat N, Hammersmith KM, Rocha FN, et al. Acanthamoeba keratitis: a parasite on the rise. Cornea. 2007 Jul;26(6):701-6. Resumo
16. Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis predisposing factors and morbidity. Ophthalmology. 2006 Jan;113(1):109-16. Resumo
17. Tauber J, Sainz de la Maza M, Hoang-Xuan T, et al. An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea. 1990 Jan;9(1):66-73. Resumo
18. Austin A, Lietman T, Rose-Nussbaumer J. Update on the management of infectious keratitis. Ophthalmology. 2017 Nov;124(11):1678-89.Texto completo Resumo
19. Herretes S, Wang X, Reyes JM. Topical corticosteroids as adjunctive therapy for bacterial keratitis. Cochrane Database Syst Rev. 2014 Oct 16;(10):CD005430.Texto completo Resumo
20. Srinivasan M, Mascarenhas J, Rajaraman R, et al; Steroids for Corneal Ulcers Trial Group. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol. 2012 Feb;130(2):143-50.Texto completo Resumo
21. Lalitha P, Srinivasan M, Rajaraman R, et al. Nocardia keratitis: clinical course and effect of corticosteroids. Am J Ophthalmol. 2012 Dec;154(6):934-9. Resumo
22. Garg P, Vazirani J. Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea? Expert Rev Ophthalmol. 2013;8:41-4.
23. Hanet MS, Jamart J, Chaves AP. Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: systematic review and meta-analysis of comparative studies. Can J Ophthalmol. 2012 Dec;47(6):493-9. Resumo
24. Centers for Disease Control and Prevention. Gonococcal infections: gonococcal infections in adolescents and adults. 2015 sexually transmitted diseases treatment guidelines. 2015 [internet publication].Texto completo
25. American Academy of Ophthalmology; White ML, Chodosh J. Herpes simplex virus keratitis: a treatment guideline. Jun 2014 [internet publication].Texto completo
26. Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2015 Jan 9;(1):CD002898.Texto completo Resumo
27. Kaufman HE, Haw WH. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis. Curr Eye Res. 2012 Jul;37(7):654-60. Resumo
28. Guess S, Stone DU, Chodosh J, et al. Evidence-based treatment of herpes simplex virus keratitis: a systematic review. Ocul Surf. 2007 Jul;5(3):240-50. Resumo
29. FlorCruz NV, Evans JR. Medical interventions for fungal keratitis. Cochrane Database Syst Rev. 2015 Apr 9;(4):CD004241.Texto completo Resumo
30. Alkharashi M, Lindsley K, Law HA, et al. Medical interventions for acanthamoeba keratitis. Cochrane Database Syst Rev. 2015 Feb 24;(2):CD010792.Texto completo Resumo
31. National Institute for Health and Care Excellence. Cenegermin for treating neurotrophic keratitis. Jul 2018 [internet publication].Texto completo
32. Lin A, Rhee MK, Akpek EK, et al. Bacterial keratitis preferred practice pattern. Ophthalmology. 2019 Jan;126(1):P1-P55.Texto completo Resumo
33. Papaioannou L, Miligkos M, Papathanassiou M. Corneal collagen cross-linking for infectious keratitis: a systematic review and meta-analysis. Cornea. 2016 Jan;35(1):62-71. Resumo
34. Ti SE, Scott JA, Janardhanan P, et al. Therapeutic keratoplasty for advanced suppurative keratitis. Am J Ophthalmol. 2007 May;143(5):755-62. Resumo
35. Iyer SA, Tuli SS, Wagoner RC. Fungal keratitis: emerging trends and treatment outcomes. Eye Contact Lens. 2006 Dec;32(6):267-71. Resumo
36. Labetoulle M, Auquier P, Conrad H, et al. Incidence of herpes simplex virus keratitis in France. Ophthalmology. 2005 May;112(5):888-95. Resumo
37. Branco BC, Gaudio PA, Margolis TP. Epidemiology and molecular analysis of herpes simplex keratitis requiring primary penetrating keratoplasty. Br J Ophthalmol. 2004 Oct;88(10):1285-8. Resumo
38. Bhatt UK, Abdul Karim MN, Prydal JI, et al. Oral antivirals for preventing recurrent herpes simplex keratitis in people with corneal grafts. Cochrane Database Syst Rev. 2016 Nov 30;11:CD007824.Texto completo Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal